By-Health Co.Ltd(300146) 3 issued the 2021 annual report on March 4. During the reporting period, the company achieved an operating revenue of 7.431 billion yuan, an increase of 21.93% over the same period of the previous year; The net profit attributable to shareholders of listed companies was 1.754 billion yuan, an increase of 15.07% over the same period last year.
The main brand " By-Health Co.Ltd(300146) " achieved a revenue of 4.445 billion yuan, a year-on-year increase of 24.36%; The joint care brand "jianliduo" achieved a revenue of 1.408 billion yuan, a year-on-year increase of 7.46%; The revenue of "life space" Chinese products was 184 million yuan, a year-on-year increase of 36.33%. Offline channel revenue accounted for about 64.29% of domestic revenue, with a year-on-year increase of 8.58%; Online channel revenue increased by 45.88% year-on-year.
LSG achieved an overseas revenue of 659 million yuan, a year-on-year increase of 16.20%.
In 2021, the company will focus on strategic priorities and continue to build its unique core competitive advantage; Break the existing organizational inertia and establish a more innovative, young and efficient flexible organization; Comprehensively layout high potential market segments and promote business growth with multiple engines; Increase the depth of business penetration and establish the sustainable development ability of life space; Promote factory upgrading and build an intelligent and agile factory.
